Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 64.22 Billion | USD 83.93 Billion | CAGR at 3.02% | 2023 |
According to the report published by Zion Market Research, The Global Legalized Cannabis market was valued at USD 64.22 Billion in 2023 and is predicted to reach USD 83.93 Billion by the end of 2032. The market is expected to grow with a CAGR of 3.02% during the forecast period. The report analyzes the Global Legalized Cannabis Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the rising opportunities in the Legalized Cannabis market.
Though cannabis is popular across the globe, it is an illegally utilized drug, as its use for various purposes is banned by myriad governments worldwide. There are several names for the product, including hemp and marijuana. Hemp is used for psychological disorders as it has non-psychotic effects on patients. Marijuana is used for medical or therapeutic purposes as well as recreational use.
Today, many developed nations are legalizing the use of the product for medical and recreational purposes. This, in turn, will generate new avenues for the players to increase their business. Apart from this, the escalating need for legalized cannabis in medical treatment and the pharmaceutical industry will further amplify the growth trends of the legalized cannabis market. Medical experts and renowned physicians are of the view that legalized cannabis can effectively treat neuropsychiatric anxiety, pain, and sleep disorders. Even clinical trials have successfully supported their view. This can increase the demand for the product over the coming years.
On the other hand, medical research has found that legalized cannabis can reduce pain when treating ailments such as cancer and epilepsy. Additionally, the product offers multifaceted sensory appeal to customers. All these factors above will amplify the growth trajectory of the legalized cannabis business. Furthermore, legalized cannabis is finding a slew of applications in personal care, cosmetics, baked food items, drinks, and tinctures.
Moreover, altering lifestyles and busy work schedules have made consumers use legalized cannabis, thereby offering them comfort against symptoms of depression including insomnia, irritation, and sadness. Legalized cannabis can also offer relief to patients suffering from arthritis and inflammatory joints, thereby resulting in strong demand for the product. Nevertheless, growing cases of drug trafficking, crime, and illegal import & use of cannabis may hamper the market growth in the future.
To learn more about this report, please request a sample copy.
The legalized cannabis market can be segmented into product type, end-user, compound, and form.
Product type-wise, the market is classified into cannabis herb and cannabis resin.
Based on the end-user, the legalized cannabis market can be separated into recreational and medicinal uses.
Based on the compound, the market is divided into THC-Dominant, Balanced THC & CBD, and CBD-Dominant. Form-wise, the industry is categorized into raw and processed forms.
Report Attributes | Report Details |
---|---|
Report Name | Legalized Cannabis Market Research Report |
Market Size in 2023 | USD 64.22 Billion |
Market Forecast in 2032 | USD 83.93 Billion |
Growth Rate | CAGR of 3.02% |
Number of Pages | 201 |
Key Companies Covered | Dixie Elixirs, The Cronos Group, Canopy Growth Corporation, Aurora Cannabis, ABcann Medicinals Inc., Aphria, Maricann Group, Inc., and ABcann Medicinals, Inc. |
Segments Covered | By Product Type, By Application, By Compound and By Region |
Regions Covered | Latin America, North America, Asia Pacific, Europe, The Middle East, And Africa |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Customized purchase options are available to meet your exact research needs. Request For Customization |
Based on the region, the global legalized cannabis market can be divided into five main areas: Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. Nearly thirty-four states in the United States of America have passed legislation legalizing cannabis for medical purposes and ten states among these thirty-four have legalized cannabis for both therapeutic and recreational purposes. In 2018, Canada legalized the farming, acquisition, and use of cannabis as well as its by-products. With most of the states in the U.S. and Canada legalizing the use of cannabis, it is more likely that the legalized cannabis market in North America will gain traction in the forthcoming years.
Uruguay became the first country in the world to legalize the use of cannabis, thereby opening the gates for the cannabis business in the Latin American region. This, in turn, will encourage market players to invest in the region and thus help the legalized cannabis market in Latin America flourish and have bright growth prospects.
Reportedly, European and Australian governments are also keen on legalizing the use of cannabis for medical purposes after studying the pros & cons of the product on human health.
A few of the main participants in the legalized cannabis market are
By Product type
By Application
FrequentlyAsked Questions
One of the major factors driving the growth of the global legalized cannabis market Increasing acceptance of medical cannabis: Medical cannabis is becoming increasingly accepted as a valid treatment option for a variety of medical conditions, including chronic pain, nausea related to chemotherapy, and multiple sclerosis. This is driving the growth of the global legalized cannabis market.
The use of cannabis and its derivatives, such as marijuana and hemp, for recreational, medical, or industrial purposes that is sanctioned by a state or federal government is referred to as "legalised cannabis." This can include permitting the production of cannabis for personal use, the selling of cannabis products in licenced storefronts or online, the possession of limited amounts of cannabis for recreational use, and the cultivation of cannabis for personal use. While some states have legalised cannabis for both medical and recreational use, others have limited their approval of the drug to its use in the treatment of medical conditions.
Few of the main participants in legalized cannabis market are Dixie Elixirs, The Cronos Group, Canopy Growth Corporation, Aurora Cannabis, ABcann Medicinals, Inc., Aphria, Maricann Group, Inc., and ABcann Medicinals, Inc.
It is anticipated that the region of North America will make the highest contributions towards the income of the global cannabis market once it is legalised. The United States of America and Canada are now the two largest markets for cannabis, and it is anticipated that these two countries will continue to dominate the market in the years to come.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed